The expression levels of mitochondrial ribosomal proteins L18 (MRPL18), L37 (MLRP37) and L9 (MRPL9), all of which induce translation of mRNAs following translocation to mitochondria, and which include family members associated with cancer [77,78,79,80], were unchanged following short-term treatment, yet decreased following long-term shVDAC1 treatment (3-, 4-, and 25-fold, respectively) (Figure 11A, Table S8). This evidence concerns the gene RPL37 and cancer.